Improving Patient Involvement in the Drug Development Process: Case Study of Potential Applications from an Online Peer Support Network

Abstract

To date, social media has been used predominantly by the pharmaceutical industry to market products and to gather feedback and comments on products from consumers, a process termed social listening. However, social media has only been used cautiously in the drug development cycle, mainly because of regulations, restrictions on engagement with patients, or a lack of guidelines for social media use from regulatory bodies. Despite this cautious approach, there is a clear drive, from both the industry and consumers, for increased patient participation in various stages of the drug development process. The authors use the example of HealthUnlocked, one of the world's largest health networks, to illustrate the potential applications of online health communities as a means of increasing patient involvement at various stages of the drug development process. Having identified the willingness of the user population to be involved in research, numerous ways to engage users on the platform have been identified and explored. This commentary describes some of these approaches and reports how online health networks that encourage people to share their experiences in managing their health can, in turn, enable rapid patient engagement for clinical research within the constraints of industry regulation.

Social media addiction and sexual dysfunction among Iranian women: The mediating role of intimacy and social support

“…The rapid growth in communication and information technologies has made it increasingly easier to access Internet worldwide. In 2017, approximately 3.77 billion people of the world's population accessed the Internet through their own smartphones or computers (Anand, Brandwood, & Jameson Evans, 2017). The penetration rate of Internet use among young people aged 15-24 years has been estimated to be 94% in developed countries and 67% in developing countries (International Telecommunication Union, 2017).…”

Public Perspectives of Using Social Media Data to Improve Adverse Drug Reaction Reporting: A Mixed-Methods Study

“…Communities vary in size; some of the larger communities have memberships in the tens of thousands [20], particularly those associated with common conditions or run by major health charities, for example, the National Rheumatoid Arthritis Society (N > 29,000), Asthma UK (N > 16,000) and the Anxiety and Depression Association of America (N > 50,000). The platform has also been used for scientific purposes, including conducting research into the dynamics among online communities for people with long-term conditions [21], describing the representativeness of users compared to wider patient populations [22] and involving patients in the drug development process [23].…”

Online Health Communities: an alternative feasible data registry tool for developing countries

“…Other studies indicated that OHC increased patient empowerment which consequently improved health outcomes [ 39 ]. Additionally, the studies also address various themes and perspectives such as patient perception [ 40 ], patients reported outcomes (PROs) [ 41 ], crowdsourcing, patient-centeredness [ 42 , 43 ], pharmacovigilance and adverse drug reactions reporting [ 44 ], drug development process [ 45 ] and off-label prescribing [ 46 ].…”